Quinupristin dalfopristin how supplied: Difference between revisions
Jump to navigation
Jump to search
(Created page with "__NOTOC__ {{Quinupristin dalfopristin }} {{CMG}}; {{AE}} {{chetan}} <ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = SYNERCID (QUINUPRISTIN AND DA...") |
No edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}}; {{AE}} {{chetan}} | {{CMG}}; {{AE}} {{chetan}} | ||
==How Supplied== | |||
<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = SYNERCID (QUINUPRISTIN AND DALFOPRISTIN) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [PFIZER LABORATORIES DIV PFIZER INC] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=28f698df-b584-4455-2e94-6efc41313960 | publisher = | date = | accessdate = }}</ref> | Synercid is supplied as a sterile lyophilized pyrogen-free preparation in single-dose 10 mL type I glass vials with gray elastomeric closure, and aluminum seal with a dark blue flip-off cap for the 500 mg vial. <ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = SYNERCID (QUINUPRISTIN AND DALFOPRISTIN) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [PFIZER LABORATORIES DIV PFIZER INC] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=28f698df-b584-4455-2e94-6efc41313960 | publisher = | date = | accessdate = }}</ref> | ||
{| | |||
|- | |||
| [[File:|800px|thumb]] | |||
|- | |||
|} | |||
==References== | ==References== | ||
Latest revision as of 06:01, 9 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Chetan Lokhande, M.B.B.S [2]
How Supplied
Synercid is supplied as a sterile lyophilized pyrogen-free preparation in single-dose 10 mL type I glass vials with gray elastomeric closure, and aluminum seal with a dark blue flip-off cap for the 500 mg vial. [1]
| [[File:|800px|thumb]] |
References
Adapted from the FDA Package Insert.